Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SHRUTI CHATURVEDI

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1508154345
CMS profile
405907
Location
BALTIMORE, MD

General Payments · PY2018–2024

$225,042.77

  • Reported across 96 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$76,668.26

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Alexion Pharmaceuticals, Inc. $33,753.40 18
GENZYME CORPORATION $20,572.18 7
Takeda Pharmaceuticals U.S.A., Inc. $12,809.00 2
NOVARTIS PHARMACEUTICALS CORPORATION $8,100.00 3
Kyowa Hakko Kirin Co., Ltd $1,373.75 1
SOBI, INC $59.93 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,175.04 4
PY2019 $12,770.88 16
PY2020 $12,574.00 8
PY2021 $29,400.00 10
PY2022 $38,338.67 14
PY2023 $51,115.92 12
PY2024 $76,668.26 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $1,860.00 01/11/2024 Consulting Fee Undisputed 01/23/2026 1093991365 CMS
Alexion Pharmaceuticals, Inc. $400.02 02/24/2024 Travel and Lodging Undisputed 01/23/2026 1093885685 CMS
Alexion Pharmaceuticals, Inc. $39.10 02/24/2024 Food and Beverage Undisputed 01/23/2026 1093886129 CMS
Alexion Pharmaceuticals, Inc. $15.64 02/24/2024 Food and Beverage Undisputed 01/23/2026 1094009537 CMS
Alexion Pharmaceuticals, Inc. $35.78 03/13/2024 Travel and Lodging Undisputed 01/23/2026 1093943590 CMS
Alexion Pharmaceuticals, Inc. $10,540.00 03/13/2024 Consulting Fee Undisputed 01/23/2026 1093973474 CMS
Alexion Pharmaceuticals, Inc. $90.80 03/13/2024 Food and Beverage Undisputed 01/23/2026 1094005577 CMS
Alexion Pharmaceuticals, Inc. $369.08 05/03/2024 Travel and Lodging Undisputed 01/23/2026 1093963700 CMS
Alexion Pharmaceuticals, Inc. $50.00 05/04/2024 Food and Beverage Undisputed 01/23/2026 1093887708 CMS
Alexion Pharmaceuticals, Inc. $16.43 05/04/2024 Food and Beverage Undisputed 01/23/2026 1093961094 CMS
Alexion Pharmaceuticals, Inc. $24.99 05/04/2024 Food and Beverage Undisputed 01/23/2026 1094031962 CMS
Alexion Pharmaceuticals, Inc. $40.00 05/04/2024 Food and Beverage Undisputed 01/23/2026 1094039127 CMS
Alexion Pharmaceuticals, Inc. $77.56 06/12/2024 Food and Beverage Undisputed 01/23/2026 1093940177 CMS
Alexion Pharmaceuticals, Inc. $44.00 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1094023510 CMS
Alexion Pharmaceuticals, Inc. $9,300.00 06/12/2024 Consulting Fee Undisputed 01/23/2026 1094037918 CMS
Alexion Pharmaceuticals, Inc. $620.00 07/04/2024 Consulting Fee Undisputed 01/23/2026 1093984438 CMS
Alexion Pharmaceuticals, Inc. $4,650.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1093956333 CMS
Alexion Pharmaceuticals, Inc. $5,580.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1093932530 CMS
GENZYME CORPORATION $10,351.00 03/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139841401 CMS
GENZYME CORPORATION $50.00 11/09/2024 Food and Beverage Undisputed 01/23/2026 1139841389 CMS
GENZYME CORPORATION $44.32 11/09/2024 Food and Beverage Undisputed 01/23/2026 1139841391 CMS
GENZYME CORPORATION $42.18 11/09/2024 Travel and Lodging Undisputed 01/23/2026 1139841393 CMS
GENZYME CORPORATION $49.72 11/09/2024 Travel and Lodging Undisputed 01/23/2026 1139841395 CMS
GENZYME CORPORATION $62.96 11/09/2024 Travel and Lodging Undisputed 01/23/2026 1139841397 CMS
GENZYME CORPORATION $9,972.00 11/09/2024 Consulting Fee Undisputed 01/23/2026 1139841399 CMS
Kyowa Kirin Co., Ltd $1,373.75 11/15/2024 Consulting Fee Undisputed 01/23/2026 1127043173 CMS
Novartis Pharmaceuticals Corporation $2,700.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1086770805 CMS
Novartis Pharmaceuticals Corporation $3,375.00 09/27/2024 Consulting Fee Undisputed 01/23/2026 1086770809 CMS
Novartis Pharmaceuticals Corporation $2,025.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1086770811 CMS
SOBI, INC $59.93 12/06/2024 Food and Beverage Undisputed 01/23/2026 1141411372 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,409.00 04/29/2024 Consulting Fee Undisputed 01/23/2026 1137508390 CMS
Takeda Pharmaceuticals U.S.A., Inc. $10,400.00 11/20/2024 Consulting Fee Undisputed 01/23/2026 1137508394 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.